The St. Jude researchers demonstrated that the Brca2 gene plays a dual role in the
developing nervous system, eliminating errors in the DNA of newly made copies of
chromosomes and suppressing the onset of the brain cancer medulloblastoma.
Feasibility of Four Consecutive High-Dose Chemotherapy
Cycles With Stem-Cell Rescue for Patients With Newly
Diagnosed Medulloblastoma or Supratentorial Primitive
Neuroectodermal Tumor After Craniospinal Radiotherapy:
Results of a Collaborative Study
Vaccine May Double Survival In Patients With Deadly Brain Tumors
Jun. 3, 2008 — A vaccine aimed at inducing immunity to the most common and deadly type of brain tumor may stave off recurrence and more than double survival in patients, according to a new study led by researchers in Duke's Preston Robert Tisch Brain Tumor Center.
Unraveling Brain Tumors
Molecular Biologists Devise Strategy To Starve Brain Tumors
September 1, 2007 — Brain tumor researchers have found that brain tumors arise from cancer stem cells living within tiny protective areas formed by blood vessels in the brain. Killing those cells is a promising strategy to eliminate tumors and prevents them from re-growing. The researchers have found that drugs that block new blood vessel formation can destroy the protected areas and stop cancer from developing.
Herbal Therapy for Brain Cancer
Phase II Randomized Study of Adjuvant Boswellia Serrata and Standard Treatment Versus Standard Treatment Alone in Patients with Newly Diagnosed or Recurrent High-Grade Gliomas (CASE-CCF-7348). See the protocol summary at http://www.cancer.gov/clinicaltrials/CASE-CCF-7348.
Principal Investigator: Dr. Glen Stevens, Cleveland Clinic Foundation